High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in North-Eastern Poland

Journal of Medical Virology

Volumn 80, Issue 4, 2008, Pages 615-618

  Chlabicz, S ^a,b   Flisiak, R ^a   Kowalczuk, O ^a   Wiercinska Drapalo A ^a   Pytel Krolczuk, B ^a   Prokopowicz, D ^a   Chyczewski, L ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Family Medicine and Community Nursing ^*  (Poland)

Author keywords

Genotype; Hepacivirus; Hepatitis C; Intravenous; Substance abuse

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; POLAND; PREVALENCE; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

5' UNTRANSLATED REGIONS; ADULT; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; POLAND; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SUBSTANCE ABUSE, INTRAVENOUS;

HEPACIVIRUS; HEPATITIS C VIRUS;

EID: 40549130696     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21107     Document Type: Article

References (32)

1. Abdo AA, Lee SS. 2004. Management of hepatitis C virus genotype 4. J Gastroenterol Hepatol 19:1233-1239.
2. Aguilera A, Losada E, Novoa S, Seoane R, Otero L, Gonzalez-Quintela A, Delgado M, Prieto A, Regueiro BJ. 2003. High prevalence of infection by hepatitis C virus genotype 4 in northern Spain intravenous drug users with HIV infection. Antivir Ther 8: abstract no. 957. S454
3. Brojer E, Gronowska A, Medyńska J, Grabarczyk P, Mikulska M, Letowska M, Kryczka W, Gietka A. 2004. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland. Transfusion 44: 1706-1710.
4. Chlabicz S, Bonifatiuk I, Radziwon P. 2005. Prevalence of hepatitis C virus antibodies among blood donors in north-eastern Poland. Hepatol Res 33:206-210.
5. Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A. 2000. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children. Med Sci Monit 6:964-970.
6. Delwaide J, Reenaers C, Gerard C, Vaira D, Bastens B, Servais B, Bekhti A, Bataille C, Wain E, De Leeuw P, Daenen G, Mesureur T, Sente JM, Belaïche J. Groupe Liégeois d'Etude des Virus Hépatotropes. 2006. HCV genotype 4 in Belgium: Three distinct patterns among patients from European and African origin. Eur J Gastroenterol Hepatol 18:707-712.
7. Fernández-Arcás N, López-Siles J, Trapero S, Ferraro A, Ibáñez A, Orihuela F, Maldonado J, Alonso A. 2006. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): Phylogenetic and epidemiological analyses. J Med Virol 78:1429-1435.
8. Halota W, Opoka J, Trzciński J, Dorau M, Topczewska E, Giziński W, Bulik F. 1991. Serological markers of selected viral infections transmitted by parenteral route in drug addicts. Przegl Epidemiol 45:347-349.
9. Imberti L, Cariani E, Bettinardi A, Zonaro A, Albertini A, Primi D. 1991. An immunoassay for specific amplified HCV sequences. J Virol Methods 34:233-243.
10. Kao JH, Chen DS. 2000. Transmission of hepatitis C virus in Asia: Past and present perspectives. J Gastroenterol Hepatol 15:E91-E96.
11. Laskus T, Radkowski M, Werezynska T, Horban A, Lupa E, Cianciara J, Slusarczyk J. 1992. Occurrence of antibodies against hepatitis C virus (HCV) among drug addicts. Pol Arch Med Wewn 87:8-13.
12. Martinez SM, Delgado MB, Castroagudin JF, Aguilera A. 2005. High rate of infection with hepatitis C virus genotype 4 in a district of Galicia, Spain. J Clin Microbiol 43:5403-5404.
13. Matera G, Lamberti A, Quirino A, Foca D, Giancotti A, Barreca GS, Guadagnino V, Liberto MC. 2002. Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis 42:169-173.
14. Matheï C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F. 2005. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: Association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Eur J Clin Microbiol Infect Dis 24:514-522.
15. Nguyen MH, Keeffe EB. 2005. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol 3:S97-S101.
16. Nolte FS, Green AM, Fiebelkorn KR, Caliendo AM, Sturchio C, Grunwald A, Healy M. 2003. Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5′ noncoding region. J Clin Microbiol 41:1558-1564.
17. Ramos B, Núñez M, Toro C, Sheldon J, García-Samaniego J, Ríos P, Soriano V. 2007. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients. J Infect 54:173-179.
18. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698-707.
19. Remy AJ, Verdier E, Perney P, Ducos J, Blanc P, Blanc F, Larrey D. 1998. Route of infection, liver histology and response to interferon in patients with chronic hepatitis caused by genotype 4 HCV infection in a Western country. J Hepatol 29:169.
20. Sanchez-Quijano A, Abad MA, Torronteras R, Rey C, Pineda JA, Leal M, Macias J, Lissen E. 1997. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 27:25-29.
21. Schroter M, Zollner B, Schafer P, Reimer A, Muller M, Laufs R, Feucht HH. 2002. Epidemiological dynamics of hepatitis C virus among 747 German individuals: New subtypes on the advance. J Clin Microbiol 40:1866-1868.
22. Seyfried H, Brojer E, Grabarczyk P, Rosinska M, Gronowska A, Letowska M. 2005. Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003. Przegl Epidemiol 59:807-814.
23. Sherman KE, Rouster SD, Chung RT, Rajicic N. 2002. Hepatitis C virus prevalence among patients coinfected with human immunodeficiency virus: A crosssectional analysis of the U.S. Adult AIDS Clinical Trials Group. Clin Infect Dis 34:831-837.
24. Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN. 1999. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 58:44-48.
25. Smiatacz T, Wlasiuk M, Paszkiewicz J, Zielinska W. 1991. HBV, HCV and HIV infections among drug addicts-residents of rehabilitation and social adjustment centers in the Gdansk district. Przegl Epidemiol 45:351-355.
26. Stanczak JJ, Opoka-Kegler J, Czerwionka-Szaflarska M, Karczewska K, Wozniakowska-Gesicka T, Horban A. 1999. Distribution of hepatitis C virus genotypes in Poland. J Hepatol 31:574.
27. Sulkowski MS, Thomas DL. 2003. Hepatitis C in the HIV-Infected person. Ann Intern Med 138:197-207.
28. Szaflarska-Szczepanik A, Czerwionka-Szaflaska M, Chrobot A. 1999. HCV genotypes in children and young adults with chronic viral hepatitis C in self-selected material. Med Sci Monit 5:514-518.
29. Tien PC. Veterans Affairs Hepatitis C Resource Center Program, National Hepatitis C Program Office. 2005. Management and Treatment of Hepatitis C Virus Infection in HIV-infected Adults: Recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am J Gastroenterol 100:2338-2354.
30. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S. European and Italian Seroconverter Studies. 2004. Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis. J Infect Dis 189:292-302.
31. Woźniakowska-Gȩsicka T, Zeman K, Kups J. 1997. Analysis of frequency of occurrence of HCV-RNA and HCV genotypes in children with chronic hepatitis. Hepatol Pol 4:127-131. (in Polish).
32. Wysocki J, Sluzewski W, Tondel G. 1994. Genotypes of hepatitis C virus (HCV) in selected group of children with chronic hepatitis. Hepatol Pol 1:59-66. (in Polish).